Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Shares, $0.001 par value
-
Shares outstanding
-
104M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
10M
-
Shares change
-
-33.2M
-
Total reported value, excl. options
-
$142M
-
Value change
-
-$492M
-
Number of buys
-
32
-
Number of sells
-
-61
-
Price
-
$14.26
Significant Holders of BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) as of Q2 2025
111 filings reported holding BMEZ - BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value as of Q2 2025.
BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10M shares
of 104M outstanding shares and own 9.65% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (1.77M shares), BANK OF AMERICA CORP /DE/ (1.47M shares), UBS Group AG (1.17M shares), Penserra Capital Management LLC (1.16M shares), RAYMOND JAMES FINANCIAL INC (710K shares), WELLS FARGO & COMPANY/MN (676K shares), Invesco Ltd. (651K shares), Royal Bank of Canada (417K shares), STIFEL FINANCIAL CORP (261K shares), and LPL Financial LLC (189K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.